RWD and its applications in the pharmaceutical industry was the topic of the fourth virtual meet-up sponsored by the National Institute of Statistical Sciences and Merck and co-sponsored by the ASA’s Health Policy Statistics Section for the first time this year. Big data, real-world data, and observational data have become ubiquitous and essential components of the drug development and commercialization process.
Amstat News
The Membership Magazine of the American Statistical Association